BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 25602444)

  • 1. The association between preoperative serum C-reactive protein and hepatocellular carcinoma recurrence in patients with chronic hepatitis B virus (HBV) infection--a retrospective study.
    Zhao X; Luo J; Li B; Liu S; Li D
    PLoS One; 2015; 10(1):e0116909. PubMed ID: 25602444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of preoperative serum C-reactive protein on the prognosis of patients with hepatocellular carcinoma.
    Hashimoto K; Ikeda Y; Korenaga D; Tanoue K; Hamatake M; Kawasaki K; Yamaoka T; Iwatani Y; Akazawa K; Takenaka K
    Cancer; 2005 May; 103(9):1856-64. PubMed ID: 15779015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Relationship Between Serum Interleukin-6 and the Recurrence of Hepatitis B Virus Related Hepatocellular Carcinoma after Curative Resection.
    Sheng T; Wang B; Wang SY; Deng B; Qu L; Qi XS; Wang XL; Deng GL; Sun X
    Medicine (Baltimore); 2015 Jun; 94(24):e941. PubMed ID: 26091457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum C-reactive protein is a useful biomarker for predicting outcomes after liver transplantation in patients with hepatocellular carcinoma.
    An HJ; Jang JW; Bae SH; Choi JY; Yoon SK; Lee MA; You YK; Kim DG; Jung ES
    Liver Transpl; 2012 Dec; 18(12):1406-14. PubMed ID: 22821639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postoperative peak serum C-reactive protein predicts outcome of hepatic resection for hepatocellular carcinoma.
    Shiba H; Furukawa K; Fujiwara Y; Futagawa Y; Haruki K; Wakiyama S; Ishida Y; Misawa T; Yanaga K
    Anticancer Res; 2013 Feb; 33(2):705-9. PubMed ID: 23393371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postoperative serum osteopontin level is a novel monitor for treatment response and tumor recurrence after resection of hepatitis B-related hepatocellular carcinoma.
    Zhou C; Zhou HJ; Zhang XF; Lou LL; Ye QH; Zheng Y; Wang J; Zhu HT; Dong QZ; Jia HL; Zhu WW; Guo L; Zhao Y; Gao DM; Qin LX
    Ann Surg Oncol; 2013 Mar; 20(3):929-37. PubMed ID: 23203407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HBV DNA and HBsAg levels as risk predictors of early and late recurrence after curative resection of HBV-related hepatocellular carcinoma.
    Sohn W; Paik YH; Kim JM; Kwon CH; Joh JW; Cho JY; Gwak GY; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC
    Ann Surg Oncol; 2014 Jul; 21(7):2429-35. PubMed ID: 24619495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pretransplant serum levels of C-reactive protein predict prognoses in patients undergoing liver transplantation for hepatocellular carcinoma.
    Kim YK; Kim SH; Lee SD; Hong SK; Park SJ
    Transplant Proc; 2015 Apr; 47(3):686-93. PubMed ID: 25891712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of recurrence after hepatic resection in patients with hepatitis B vs. hepatitis C-related small hepatocellular carcinoma in hepatitis B virus endemic area.
    Huang YH; Wu JC; Chen CH; Chang TT; Lee PC; Chau GY; Lui WY; Chang FY; Lee SD
    Liver Int; 2005 Apr; 25(2):236-41. PubMed ID: 15780044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pre-treatment C-reactive protein as a prognostic factor for recurrence after surgical resection of hepatocellular carcinoma.
    Nishikawa H; Arimoto A; Wakasa T; Kita R; Kimura T; Osaki Y
    Anticancer Res; 2013 Mar; 33(3):1181-8. PubMed ID: 23482800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Posthepatectomy HBV reactivation in hepatitis B-related hepatocellular carcinoma influences postoperative survival in patients with preoperative low HBV-DNA levels.
    Huang G; Lai EC; Lau WY; Zhou WP; Shen F; Pan ZY; Fu SY; Wu MC
    Ann Surg; 2013 Mar; 257(3):490-505. PubMed ID: 22868358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in surgical outcomes between hepatitis B- and hepatitis C-related hepatocellular carcinoma: a retrospective analysis of a single North American center.
    Franssen B; Alshebeeb K; Tabrizian P; Marti J; Pierobon ES; Lubezky N; Roayaie S; Florman S; Schwartz ME
    Ann Surg; 2014 Oct; 260(4):650-6; discussion 656-8. PubMed ID: 25203882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High preoparative levels of serum periostin are associated with poor prognosis in patients with hepatocellular carcinoma after hepatectomy.
    Lv Y; Wang W; Jia WD; Sun QK; Huang M; Zhou HC; Xia HH; Liu WB; Chen H; Sun SN; Xu GL
    Eur J Surg Oncol; 2013 Oct; 39(10):1129-35. PubMed ID: 23916473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum C-reactive protein levels predict survival in hepatocellular carcinoma.
    Nagaoka S; Yoshida T; Akiyoshi J; Akiba J; Torimura T; Adachi H; Kurogi J; Tajiri N; Inoue K; Niizeki T; Koga H; Imaizumi T; Kojiro M; Sata M
    Liver Int; 2007 Oct; 27(8):1091-7. PubMed ID: 17845537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathological and prognostic significance of preoperative serum zinc status in patients with hepatocellular carcinoma after initial hepatectomy.
    Imai K; Beppu T; Yamao T; Okabe H; Hayashi H; Nitta H; Hashimoto D; Mima K; Nakagawa S; Sakamoto K; Chikamoto A; Ishiko T; Baba H
    Ann Surg Oncol; 2014 Nov; 21(12):3817-26. PubMed ID: 24841354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparison of prognosis of small hepatocellular carcinoma patients with hepatitis B virus infection versus hepatitis C virus infection].
    Li HK; Qin Y; Li XM; Li Q
    Zhonghua Gan Zang Bing Za Zhi; 2009 Jun; 17(6):426-8. PubMed ID: 19567020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathologic characteristics of patients with non-B non-C hepatitis virus hepatocellular carcinoma after hepatectomy.
    Kaibori M; Ishizaki M; Matsui K; Kwon AH
    Am J Surg; 2012 Sep; 204(3):300-7. PubMed ID: 22591698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing prognostic significance of preoperative alpha-fetoprotein in hepatitis B-associated hepatocellular carcinoma: normal is not the new normal.
    Blank S; Wang Q; Fiel MI; Luan W; Kim KW; Kadri H; Mandeli J; Hiotis SP
    Ann Surg Oncol; 2014 Mar; 21(3):986-94. PubMed ID: 24232510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of hepatitis B virus infection in the prognosis after hepatectomy for hepatocellular carcinoma in patients with cirrhosis: a Western dual-center experience.
    Cescon M; Cucchetti A; Grazi GL; Ferrero A; ViganĂ² L; Ercolani G; Ravaioli M; Zanello M; Andreone P; Capussotti L; Pinna AD
    Arch Surg; 2009 Oct; 144(10):906-13. PubMed ID: 19841357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Higher efficacy of antiviral therapy after major hepatectomy in patients with hepatitis B virus-related hepatocellular carcinoma of less than 3 cm.
    Zhang ZY; Zhou ZQ; Zhou GW
    Eur J Gastroenterol Hepatol; 2014 Oct; 26(10):1116-24. PubMed ID: 25003747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.